deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT01741415

Distress Tolerance Treatment for Substance Users

Sponsor: University of South Florida

Interventions SC SIDI
Updated 8 times since 2017 Last updated: Oct 10, 2018 Started: May 13, 2013 Primary completion: Sep 12, 2018 Completion: Sep 1, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01741415, this PHASE2 trial focuses on Substance Dependence and remains ongoing. Sponsored by University of South Florida, it has been updated 8 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Mar 2018 · 14 months · monthly snapshotRecruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotRecruiting~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotRecruiting~Nov 2018 – ~Oct 2019 · 11 months · monthly snapshotRecruiting~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  4. Oct 2019 — Jan 2021 [monthly]

    Unknown Status PHASE2

    Status: RecruitingUnknown Status

  5. Nov 2018 — Oct 2019 [monthly]

    Recruiting PHASE2

Show 3 earlier versions
  1. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  2. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

  3. Jan 2017 — Mar 2018 [monthly]

    Recruiting PHASE2

    First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of South Florida
Data source: University of South Florida

For direct contact, visit the study record on ClinicalTrials.gov .